Cellectis has over 100 million shares in capital and 89 million voting rights.

Cellectis, listed on Euronext Growth, has a total of 100,325,229 shares in capital and 89,428,630 voting rights as of June 30, 2025. For media inquiries, contact Pascalyne Wilson at +33 (0)7 76 99 14 33 and for investor relations, reach out to Arthur Stril at [email protected]. More information can be found in the monthly report for June 2025.

Read more at GlobeNewswire: Monthly information on share capital and company voting